Innovative antidiabetic drugs as the present and future of diabetes
- Authors: - -
- Issue: Vol 22, No 4 (2020)
- Pages: 11-17
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95234
- DOI: https://doi.org/10.26442/20751753.2020.4.200193
- ID: 95234
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Terra SG etal. Phase III, Efficacy and Safety Study of Ertugliflozin Monotherapy in People With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise Alone. Diabetes Obes Metab 2017; 19: 721-8.
- Rosenstock J et al. Effect of Ertugliflozin on Glucose Control, Body Weight, Blood Pressure and Bone Density in Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy (VERTIS MET). Diabetes Obes Metab 2018; 20: 520-9.
Supplementary files
